Recent Advances in Multiplex Immunoassays

10.1002/cbic.200400232

Stoll D , TemplinMF, BachmannJ, JoosTO. Protein microarrays: applications and future challenges. Curr. Opin. Drug. Disc. Dev. 8(2), 239–252 (2005).

10.1016/S0003-2670(00)82647-1

10.1073/pnas.91.11.5022

Ragoussis J , ElvidgeG. Affymetrix GeneChip® system: moving from research to the clinic. Expert Rev. Mol. Med. 6(2), 145–152 (2006).

10.1177/000456329903600603

Pla-Roca M , LeulmiRF, DjambazianH, SundararajanS, JunckerD. Addressable nanowell arrays formed using reversibly sealable hybrid elastomer-metal stencils. Anal. Chem. (2012) (In press).

Fresiello L , FranchinT, IadanzaE, De Vivo L. Clinical relevance of donor specific antibodies (DSA) detected by luminex technology: an early systematic review and meta-analysis of the literature for a hospital-based health technology assessment project. Clin. Chem. Lab. Med. 49, S755–S755 (2011).

10.1111/j.1440-1797.2008.01074.x

10.1039/b822582f

10.1007/s00216-010-3661-4

10.1039/b820557b

10.1021/ac101275s

10.1016/j.ymeth.2003.08.018

Murng SHK , EgnerW, ShrimptonA, SargurR, CowleyD, LeesK. A study of ISAC (immuno solid-phase allergen chip) assay performance and interpretation. Clin. Exp. Allergy41(12), 1839–1839 (2011).

Heaps AG , El-ShanawanyT, SelwoodCet al. Analysis of the serum IgE repertoire in hyper IgE syndrome (HIGE) patients using an immuno solid-phase allergen chip (ISAC). Clin. Exp. Immunol. 16012–16013 (2010).

10.1016/j.snb.2008.06.043

10.1016/j.ab.2011.07.038

10.1016/S0006-3495(81)84905-3

10.1016/j.snb.2008.08.043

10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E

10.1373/clinchem.2007.098418

10.1021/jf063600b

10.1309/781K5W6QH7JH2TMA

Alvarez JC . The evaluation of the first meprobamate, zopiclone, zolpidem and zaleplon antibodies using biochip multiplexing technology from randox in plasma, serum and whole blood. Clin. Chem. Lab. Med. 49, S188 (2011).

10.2478/v10011-009-0031-x

10.1111/j.1365-3083.2007.01906.x

Usui K , Tomizaki K-Y, Ohyama T, Nokiharab K, Mihara H. A novel peptide microarray for protein detection and analysis utilizing a dry peptide array system. Mol. BioSyst. 2113–121 (2006).

10.1039/B612492E

10.1002/pmic.200500721

10.1016/j.diagmicrobio.2011.06.002

Pinho TS , NazerSC, BerthoAL, PinheiroMFC, TeixeiraEH, FellowsIB. Abbott Determine™ HIV-1/2 validation as qualitative screening test. Clin. Chem. 46(6), A46 (2000).

10.1021/ac101008d

10.1039/c1an15121e

10.1016/j.bios.2011.08.031

10.1039/b819688e

10.1016/j.trac.2009.04.011

10.1016/j.bios.2010.07.110

10.1373/clinchem.2005.058727

10.1166/jbn.2006.005

10.1007/s00216-007-1536-0

lmmuno Concepts. www.immunoconcepts.com/disease-diagnostics/systemic-rheumatic-disease/colorimetric-microarray